Alame-Emane, A.K., Pierre-Audigier, C., Aboumegone-Biyogo, O.C., Nzoghe-Mveang, A., Cadet-Daniel, V., Sola, C., Djoba-Siawaya, J.F., Gicquel, B., and Takiff, H.E. (2017). Use of GeneXpert Remnants for Drug Resistance Profiling and Molecular Epidemiology of Tuberculosis in Libreville, Gabon. J. Clin. Microbiol. 55, 2105–2115.
Amona, M., Aloumba, A.J., Moukassa, D., Mouroumouyoka, A., Kokolo, B., Loumouamou, M.L., Amona, R.F., Mbita, A.M., Moubie, S., Ngankeni, G., et al. (2017). Tuberculose multirésistante. Evaluation situationnelle à l’Hôpital Central des Armées de Brazzaville au Congo. 5.
Boehme, C.C., Nabeta, P., Hillemann, D., Nicol, M.P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010). Rapid Molecular Detection of Tuberculosis and Rifampin Resistance. N Engl J Med 363, 1005–1015.
Brossier, F., Guindo, D., Pham, A., Reibel, F., Sougakoff, W., Veziris, N., and Aubry, A. (2016). Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains. J Clin Microbiol 54, 1573–1580.
Farra, A., Manirakiza, A., Yambiyo, B.M., Zandanga, G., Lokoti, B., Berlioz-Arthaud, A., Ngaya, G., Hermana, G., Ourandji, L.M., Ignaleamoko, A., et al. (2019). Surveillance of Rifampicin Resistance With GeneXpert MTB/RIF in the National Reference Laboratory for Tuberculosis at the Institut Pasteur in Bangui, 2015–2017. Open Forum Infect Dis 6.
Gardee, Y., Dreyer, A.W., Koornhof, H.J., Omar, S.V., da Silva, P., Bhyat, Z., and Ismail, N.A. (2017). Evaluation of the GenoType MTBDRsl Version 2.0 Assay for Second-Line Drug Resistance Detection of Mycobacterium tuberculosis Isolates in South Africa. J Clin Microbiol 55, 791–800.
Gilpin, C., Korobitsyn, A., and Weyer, K. (2016). Current tools available for the diagnosis of drug-resistant tuberculosis. Ther Adv Infect Dis 3, 145–151.
Harries, A.D., Schwoebel, V., Monedero-Recuero, I., Aung, T.K., Chadha, S., Chiang, C.-Y., Conradie, F., Dongo, J.-P., Heldal, E., Jensen, P., et al. (2019). Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries. Int J Tuberc Lung Dis 23, 241–251.
Horne, D.J., Kohli, M., Zifodya, J.S., Schiller, I., Dendukuri, N., Tollefson, D., Schumacher, S.G., Ochodo, E.A., Pai, M., and Steingart, K.R. (2019). Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2019.
Liu, Z., Zhang, M., Wang, J., Chen, S., Wu, B., Zhou, L., Pan, A., Wang, W., and Wang, X. (2020). Longitudinal Analysis of Prevalence and Risk Factors of Rifampicin-Resistant Tuberculosis in Zhejiang, China. BioMed Research International 2020, 1–8.
Najjingo, I., Muttamba, W., Kirenga, B.J., Nalunjogi, J., Bakesiima, R., Olweny, F., Lusiba, P., Katamba, A., Joloba, M., and Ssengooba, W. (2019). Comparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- A cross-sectional study. PLoS One 14.
Nguyen, T.N.A., Anton-Le Berre, V., Bañuls, A.-L., and Nguyen, T.V.A. (2019). Molecular Diagnosis of Drug-Resistant Tuberculosis; A Literature Review. Front Microbiol 10.
Ntoumi, F., Kaleebu, P., Macete, E., Mfinanga, S., Chakaya, J., Yeboah-Manu, D., Bates, M., Mwaba, P., Maeurer, M., Petersen, E., et al. (2016). Taking forward the World TB Day 2016 theme ‘Unite to End Tuberculosis’ for the WHO Africa Region. Int J Infect Dis 46, 34–37.
Nunn, A.J., Phillips, P.P.J., Meredith, S.K., Chiang, C.-Y., Conradie, F., Dalai, D., van Deun, A., Dat, P.-T., Lan, N., Master, I., et al. (2019). A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis. N Engl J Med 380, 1201–1213.
Okemba Okombi, F.H., Bemba, E., Bopaka, R.G., Oosale Abacka, K.B., and Kaswa, M. (2018). Extensively resistant tuberculosis: Four cases in the Republic of Congo. Med Sante Trop 28, 289–291.
Okemba-Okombi, F., Essango, E.N., Kayomo, M.K., Abacka, B.O., Bopaka, R., and Ibara, B.A. (2020). Multi-resistant tuberculosis in Brazzaville: Epidemiologi- cal, clinical, radiographic and progressive aspects. 11, 6.
Okemba-Okombi, F.H., Itoua, A., Biniakounou, J.B., Illoye-Ayet, M., Bemba, E.L.P., Ossalé Abacka, K.B., and Bopaka, R.G. (2015a). Apport du GeneXpert dans le diagnostic de la tuberculose pulmonaire : étude préliminaire et perspectives en République du Congo. Revue des Maladies Respiratoires 32, A211.
Okemba-Okombi, F.H., Itoua, A., Biniakounou, J.B., and Madzou, L. (2015b). Évaluation de la prise en charge des patients admis au régime de retraitement au Centre anti-tuberculeux de Brazzaville. Revue des Maladies Respiratoires 32, A213.
Ossibi Ibara, B., OKemba Okombi, F., Obengui, Mbemba Esther, LP., Boumandouki, J., Obame Ontsi, F., and Puruehnce, M. (2016). Associated pulmonary tuberculosis in HIV patients in Department of Infectious Diseases of the University Hospital of Brazzaville: Prevalence and Associated factors. JFVP 7, 24–28.
Pai, M., Behr, M.A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C.C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016). Tuberculosis. Nat Rev Dis Primers 2, 16076.
Phyo, K.H., Oo, M.M., Harries, A.D., Saw, S., Aung, T.K., Moe, J., Thuya, S.S., Mon, Y.Y., Min, A.C., Naing, N.N., et al. (2019). High prevalence and incidence of tuberculosis in people living with the HIV in Mandalay, Myanmar, 2011-2017. Int J Tuberc Lung Dis 23, 349–357.
Sachdeva, K.S., Raizada, N., Sreenivas, A., van’t Hoog, A.H., van den Hof, S., Dewan, P.K., Thakur, R., Gupta, R.S., Kulsange, S., Vadera, B., et al. (2015). Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India. PLoS One 10.
World Health Organization (2019). Global tuberculosis report 2019.
Zumla, A., Abubakar, I., Raviglione, M., Hoelscher, M., Ditiu, L., Mchugh, T.D., Squire, S.B., Cox, H., Ford, N., McNerney, R., et al. (2012). Drug-Resistant Tuberculosis—Current Dilemmas, Unanswered Questions, Challenges, and Priority Needs. The Journal of Infectious Diseases 205, S228–S240.